SCHEMBL29615940

SCHEMBL29615940

O=Cc1cc(Br)c(OC2CCC2)cc1[N+](=O)[O-]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
MAPT P10636 4/20 0.50
CYP3A4 P08684 3/20 0.50
ALOX15 P16050 2/20 0.50
PRKDC P78527 2/20 0.50
KDM4E B2RXH2 1/20 0.50
HSD17B10 Q99714 1/20 0.50
POLB P06746 1/20 0.46
ERN1 O75460 3/20 0.39
CYP19A1 P11511 4/20 0.36
KMT2A Q03164 4/20 0.35
MEN1 O00255 3/20 0.35
CYP1A2 P05177 2/20 0.35
CYP2D6 P10635 2/20 0.35
CYP2C19 P33261 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
PTGES O14684 1/20 0.35
TSHR P16473 1/20 0.35
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22836132 1.00 ALDH1A1 (0.50) ALDH1A1MAPTCYP3A4ALOX15PRKDC
SCHEMBL29615935 1.00 ALDH1A1 (0.50) ALDH1A1MAPTCYP3A4ALOX15PRKDC
SCHEMBL29502511 0.96 ALDH1A1 (0.51) ALDH1A1MAPTCYP3A4ALOX15PRKDC
SCHEMBL22835309 0.96 ALDH1A1 (0.51) ALDH1A1MAPTCYP3A4ALOX15PRKDC
SCHEMBL7355696 0.81 ALDH1A1 (0.71) ALDH1A1MAPTCYP3A4ALOX15PRKDC
SCHEMBL27041951 0.78 MAPT (0.48) ALDH1A1MAPTCYP3A4ALOX15PRKDC
SCHEMBL29502284 0.78 ALDH1A1 (0.76) ALDH1A1MAPTCYP3A4ALOX15PRKDC
SCHEMBL1572262 0.78 ALDH1A1 (0.76) ALDH1A1MAPTCYP3A4ALOX15PRKDC
SCHEMBL22835646 0.77 MAPT (0.53) ALDH1A1MAPTCYP3A4ALOX15PRKDC
SCHEMBL29502581 0.77 MAPT (0.53) ALDH1A1MAPTCYP3A4ALOX15PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3990432-A1 2H-INDAZOLE DERIVATIVES AND THEIR USE IN THE TREATMENT OF DISEASE Biogen MA Inc. (US) 2022-05-04 EP disclosed